Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Ultrasound-Guided technique may reduce deadly bleeding in liver cancer patients

NCT ID NCT05629845

First seen Mar 22, 2026 · Last updated May 23, 2026 · Updated 9 times

Summary

This study tests whether a newer, ultrasound-guided endoscopic procedure can better prevent dangerous rebleeding from enlarged veins in the stomach or esophagus compared to standard endoscopic treatments. The trial enrolls 84 liver cancer patients who have already had a bleeding episode controlled by standard therapy. The goal is to see which method more effectively reduces the chance of rebleeding within 90 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Prince of Wales Hospital, The Chinese University of Hong Kong

    RECRUITING

    Shatin, New Territories, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.